Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells $8,000,000.00 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Robert Williams, Jr. sold 1,000,000 shares of the stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $8.00, for a total transaction of $8,000,000.00. Following the transaction, the insider directly owned 245,251 shares in the company, valued at approximately $1,962,008. This represents a 80.31% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Aveanna Healthcare Trading Up 1.5%

Aveanna Healthcare stock traded up $0.12 during mid-day trading on Friday, hitting $8.61. The company’s stock had a trading volume of 953,109 shares, compared to its average volume of 1,436,922. The business has a 50 day moving average price of $7.10 and a 200-day moving average price of $7.57. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47. Aveanna Healthcare Holdings Inc. has a 12 month low of $3.73 and a 12 month high of $10.32. The stock has a market cap of $1.87 billion, a price-to-earnings ratio of 7.29, a price-to-earnings-growth ratio of 0.87 and a beta of 1.93.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.13 by $0.05. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The firm had revenue of $647.91 million for the quarter, compared to analysts’ expectations of $613.22 million. Aveanna Healthcare’s revenue for the quarter was up 15.9% compared to the same quarter last year. As a group, analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.65 EPS for the current year.

Institutional Trading of Aveanna Healthcare

Several large investors have recently added to or reduced their stakes in AVAH. Vanguard Group Inc. lifted its position in shares of Aveanna Healthcare by 38.0% in the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after purchasing an additional 1,535,351 shares during the period. Geode Capital Management LLC raised its stake in Aveanna Healthcare by 17.7% in the fourth quarter. Geode Capital Management LLC now owns 1,849,057 shares of the company’s stock worth $15,110,000 after buying an additional 278,429 shares in the last quarter. AustralianSuper Pty Ltd purchased a new stake in Aveanna Healthcare in the third quarter worth about $15,743,000. Nuveen LLC grew its holdings in shares of Aveanna Healthcare by 135.9% during the 4th quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock worth $12,838,000 after acquiring an additional 905,316 shares during the period. Finally, State Street Corp raised its position in shares of Aveanna Healthcare by 20.9% in the 4th quarter. State Street Corp now owns 1,483,265 shares of the company’s stock worth $12,118,000 after acquiring an additional 256,392 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. Barclays decreased their target price on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating on the stock in a research note on Monday, May 18th. Royal Bank Of Canada raised shares of Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price target for the company in a research report on Wednesday, June 3rd. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $10.00 to $11.00 in a research report on Friday, May 15th. Truist Financial upped their price objective on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the company a “hold” rating in a research note on Wednesday, May 20th. Finally, Weiss Ratings lowered shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, April 6th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $10.50.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.